MED-LIFE DISCOVERIES | the science of prevention

Stacks Image 123
Learn about our blood tests that detect risk of colorectal cancer and pancreatic cancer among the general population.
Stacks Image 48
Stacks Image 52
RCDP is a rare pediatric genetic disorder that affects plasmalogen synthesis. Our plasmalogen replacement might be the key. Learn more.
Stacks Image 77
Our plasmalogen therapy might restore the lipid component of myelin lost during the progression of Multiple Sclerosis. Learn more.

Stacks Image 84
The treatment of Parkinson's disease with L-DOPA eventually leads to dyskinesias. Our data shows that plasmalogen replacement might help.

Stacks Image 91
Our mass spectrometry lab is ISO13485 certified and licensed by CPSS. Learn more.

At MED-LIFE DISCOVERIES, we believe in a future where disease is not just treated, but prevented. Unlike conventional screening tests that detect symptoms of a disease, our research and development focuses on what goes wrong in the body - before a disease develops.

Biochemical changes within the body occur long before the symptoms of diseases such as cancer and Alzheimer's appear. This pre-symptomatic phase represents the perfect window to identify those with increased risk, and to therapeutically correct the biochemical imbalance.